Biotech Archives - Page 773 of 795

2 minute read

EXCLUSIVE: Adial Pharma’s AD04 Effective In Heavy Drinker Alcohol Use Disorder Patients

July 20, 6:45 AM

Adial Pharmaceuticals Inc's (NASDAQ: ADIL) ONWARD Phase 3 study of AD04 for Alcohol Use Disorder (AUD) achieved a statistically significant mean reduction in heavy drinking days compared to placebo.

ADIL

1 minute read

Novavax’s COVID-19 Vaccine For Adults Gets CDC Advisory Committee Recommendation

By Vandana Singh

July 20, 6:43 AM

The U.S. Centers for Disease Control and Prevention’s (CDC) advisory committee recommended using Novavax Inc’s (NASDAQ:NVAX) COVID-19 vaccine as a two-dose…

NVAX

4 minute read

Recap of Tuesday’s Biotech Catalysts – End Of The Day Summary

By Ragothaman Srinivasan

July 19, 6:11 PM

The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in adults with narcolepsy.

ALNA

1 minute read

Belite Bio Seeks FDA Clearance For Late-Stage Genetic Eye Disease Study

By Ragothaman Srinivasan

July 19, 4:32 PM

Belite Bio (NASDAQ: BLTE) submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to support Phase 3 development of its lead asset LBS-008 for treatment of Stargardt Disease (STGD1).

BLTE

1 minute read

Novavax Says FDA Determined That First Lot Of COVID Vaccine Doses Met All Release Specifications And Is Acceptable For Use Under Emergency Use Authorization; Says Expects To Ship Doses To US Government-Designated Distribution Center In Coming Days

By Bill Haddad

July 19, 4:22 PM

-Reuters

NVAX

1 minute read

Sorrento Shares Gain Following FDA’s Nod for Initial-Stage Covid-19 Study

By Ragothaman Srinivasan

July 19, 3:20 PM

Sorrento Therapeutics (NASDAQ: SRNE) announced that the U.S. Food and Drug Administration (FDA) has cleared the Phase 1 study of its candidate, STI-1558, in patients with impaired renal and hepatic function.

SRNE

1 minute read

RBC Capital Lowers Inovio Price Target As It Awaits This

By Vandana Singh

July 19, 3:14 PM

RBC Capital Markets has lowered the price target on Inovio Pharmaceuticals Inc (NASDAQ:INO) to $4 from $5 with a Sector Perform rating.…

INO

1 minute read

JMP Is Bullish On This Cancer Stock “Sees New Way to Treat Cancer”

By Vandana Singh

July 19, 3:04 PM

JMP Securities has initiated the coverage on Aura Biosciences Inc (NASDAQ:AURA) with a Market Outperform rating and a $26 risk-adjusted price target. Aura…

AURA

1 minute read

Ultragenyx Shares Tumble On Initial Efficacy Missing Expectations, This Analyst Sees ‘Viable Path Forward”

By Vandana Singh

July 19, 2:51 PM

Earlier today, Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) released updated interim GTX-102 data, including Day 128 assessments from 9 patients. The Overall CGI-C-AS…

RARE

1 minute read

‘As of today, 639 people have tested positive for orthopoxvirus in NYC, which is presumed to be monkeypox.’ – Tweet By nychealthy

By Benzinga Newsdesk

July 19, 2:01 PM

https://twitter.com/nycHealthy/status/1549454091939713025

AEMD